相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The importance of the initial period of basal insulin titration in people with diabetes
Milton Packer
DIABETES OBESITY & METABOLISM (2020)
Dapagliflozin Suppresses Hepcidin And Increases Erythropoiesis
Husam Ghanim et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease
Takashi Maruyama et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Dapagliflozin not only improves hepatic injury and pancreatic endoplasmic reticulum stress, but also induces hepatic gluconeogenic enzymes expression in obese rats
Myat Theingi Swe et al.
CLINICAL SCIENCE (2019)
Renoprotective effects of canagliflozin, a sodium glucose cotransporter 2 inhibitor, in type 2 diabetes patients with chronic kidney disease: A randomized open-label prospective trial
Hiroyuki Takashima et al.
DIABETES & VASCULAR DISEASE RESEARCH (2018)
Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease
Christoph Wanner et al.
CIRCULATION (2018)
How Does Empagliflozin Reduce Cardiovascular Mortality? Insights From a Mediation Analysis of the EMPA-REG OUTCOME Trial
Silvio E. Inzucchi et al.
DIABETES CARE (2018)
Prolyl hydroxylase domain inhibitors as a novel therapeutic approach against anemia in chronic kidney disease
Mai Sugahara et al.
KIDNEY INTERNATIONAL (2017)
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibition on renal function and albuminuria in patients with type 2 diabetes: a systematic review and meta-analysis
Lubin Xu et al.
PEERJ (2017)
Sodium Glucose Cotransporter-2 Inhibition in Heart Failure Potential Mechanisms, Clinical Applications, and Summary of Clinical Trials
Yuliya Lytvyn et al.
CIRCULATION (2017)
CV Protection in the EMPA-REG OUTCOME Trial: A Thrifty Substrate Hypothesis
Ele Ferrannini et al.
DIABETES CARE (2016)
Maladaptive Modulations of NLRP3 Inflammasome and Cardioprotective Pathways Are Involved in Diet-Induced Exacerbation of Myocardial Ischemia/Reperfusion Injury in Mice
Raffaella Mastrocola et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Sodium-glucose cotransporter-2 inhibition and the potential for renal protection in diabetic nephropathy
Marko Skrtic et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2015)
Efficacy and safety of canagliflozin alone or as add-on to other oral antihyperglycemic drugs in Japanese patients with type 2 diabetes: A 52-week open-label study
Nobuya Inagaki et al.
JOURNAL OF DIABETES INVESTIGATION (2015)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease
J. -F. Yale et al.
DIABETES OBESITY & METABOLISM (2014)
Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes
David Polidori et al.
DIABETOLOGIA (2014)
Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes
H. J. Lambers Heerspink et al.
DIABETES OBESITY & METABOLISM (2013)
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
J-F Yale et al.
DIABETES OBESITY & METABOLISM (2013)
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?
Usha Panchapakesan et al.
PLOS ONE (2013)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Potential Effects of Aggressive Decongestion During the Treatment of Decompensated Heart Failure on Renal Function and Survival
Jeffrey M. Testani et al.
CIRCULATION (2010)
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Ji-Hong Lim et al.
MOLECULAR CELL (2010)
Hypoxia Inducible Factor-2α Stabilization and Maxi-K+ Channel β1-Subunit Gene Repression by Hypoxia in Cardiac Myocytes Role in Preconditioning
Lucia Bautista et al.
CIRCULATION RESEARCH (2009)
Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1
Elhadji M. Dioum et al.
SCIENCE (2009)
AMPK activation inhibits the expression of HIF-1α induced by insulin and IGF-1
C Treins et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Regulation of erythropoietin production
KU Eckardt et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2005)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
分享论文
